Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-13

Clinical Trial Update: Botulism Toxin Injection as a Treatment for Arthritis of the Basal Thumb Joint [Phase 4]

View source ↗

Summary

Phase 4 trial update for botulism toxin injections as a treatment for arthritis of the basal thumb joint; the study was terminated with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Arthritis Multiple Joint | Phase 4 | Status: TERMINATED | Results posted: 2017-07-13